Key Points Semaglutide reduces appetite within the first two weeks, with most people reaching steady levels by 4-5 weeks of treatment Weight loss averages 2% by four weeks and 4% by eight weeks, with clinical studies showing a 15% average loss over 68 weeks Blood sugar improvements occur gradually, with A1C reductions of 1.2%-2.2% seen between 26-40 weeks, depending on medication type The medication works best when paired with healthy eating habits and regular physical activity for optimal results If youre taking semaglutide for weight loss or diabetes, youre probably wondering when youll start seeing results

FDAs concerns with unapproved GLP-1 drugs used for weight loss, United States Food and Drug Administration (2024) FDA approves first oral GLP-1 treatment for Type 2 diabetes, United States Food and Drug Administration (2019) Semaglutide for Type 2 diabetes, CADTH Health Technology Review (2023) Anti-inflammatory benefits of semaglutide: State of the art, Journal of Clinical & Translational Endocrinology (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
A total of 407 records were excluded based on title and abstract screening, and 113 full-text articles were assessed for eligibility
If you are breastfeeding: Ozempic was found in the milk of lactating rats
The tradeoff is a larger injection volume at higher doses